Chiesi / promoter

Chiesi is a research-oriented international biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and speciality care. To achieve its mission of improving people’s quality of life, the Group acts responsibly not only towards patients but also towards the communities in which it operates and the environment. Having adopted the legal status of a benefit corporation in Italy, the United States, and France, Chiesi’s commitment to creating shared value for society as a whole is legally binding and at the heart of every corporate decision. As a 2019 certified B Corp, it is part of a global movement of companies that meet high standards of social and environmental impact. The company aims to achieve Zero Net Greenhouse Gas (GHG) Emissions by 2035. Chiesi, which boasts over 85 years of experience, is headquartered in Parma, has 31 commercial branches worldwide, and employs over 7,000 people. The Parma Research Centre collaborates with six other major R&D hubs in France, the US, Canada, China, the UK, and Sweden.